Probactrix OTC Approval Sought Over Rx Path For Diarrhea Drug
This article was originally published in The Tan Sheet
Executive Summary
BioBalance Corp. plans to submit an application to FDA for OTC approval of its Probactrix antibiotic-associated diarrhea drug in the first quarter of 2004, pending positive results from an ongoing safety study